It entirely depends on your makeup
However, these studies typically involved healthy volunteers or individuals with prediabetes rather than patients already receiving GLP-1 receptor agonist therapy, limiting direct applicability to the clinical question of combination benefits
According to its FDA-approved prescribing information, patients start at a low introductory dose (typically 0.25 mg once weekly), which is not considered to be a therapeutic dose, but it helps the body acclimate to the medication
Genetic variants provide context that, combined with biomarkers and provider assessment, can support more personalized treatment conversations
In simple terms, both medications affect appetite, digestion, insulin response, and blood sugar regulation
Physiol Res 2009;58(6):855-861